Press release
Orphan Drug Market Poised for Growth with 9.7% CAGR from 2024 to 2030
Orphan Drug Market
๐๐ซ๐ฉ๐ก๐๐ง ๐๐ซ๐ฎ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
The orphan drug market, focusing on medications for rare diseases, is seeing significant growth as pharmaceutical companies receive incentives like those offered under the U.S. Orphan Drug Act (ODA) to address these unique medical needs. Although rare diseases affect only a small segment of the population, they often come with limited treatment options, creating a strong demand for specialized therapies. The orphan drug market is segmented by disease type, product type, and region, with biologics representing a prominent share. Advances in biotechnology are enhancing treatment efficacy, making biologics especially valuable in targeting genetic disorders and rare cancers, thus positioning them at the forefront of this rapidly expanding market.
๐๐๐ญ ๐๐จ๐ฎ๐ซ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐ญ๐ก๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: https://www.maximizemarketresearch.com/request-sample/342/
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐ซ๐ฉ๐ก๐๐ง ๐๐ซ๐ฎ๐ ๐๐๐ซ๐ค๐๐ญ:
Technological advancements and regulatory incentives are primary drivers accelerating the orphan drug market. Technologies such as gene editing, AI, and innovative drug delivery systems are transforming how orphan drugs are developed, enabling targeted treatments for diseases with genetic underpinnings. For example, AI is helping in identifying drug interactions, while gene therapy is showing promise in correcting genetic deficiencies. Additionally, regulatory frameworks like the Orphan Drug Act in the U.S. offer tax incentives, exclusive marketing rights, and reduced fees, incentivizing companies to invest in orphan drug development.
๐๐ซ๐ฉ๐ก๐๐ง ๐๐ซ๐ฎ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
The orphan drug market is witnessing a shift towards personalized and precision medicine, leveraging advancements in biotechnology to develop therapies that specifically target the genetic causes of rare diseases. Biologic drugs, including monoclonal antibodies and gene therapies, are gaining traction as they can address complex genetic conditions with greater efficacy. This trend is particularly visible in oncology, where rare cancer types are being treated with targeted orphan therapies like Trastuzumab, which offers hope for patients with limited options.
The unmet medical needs of rare disease patients further fuel demand in this sector. Many rare diseases lack effective treatments, creating opportunities for orphan drugs to address these gaps. Patient advocacy groups and growing awareness around rare diseases are prompting faster approvals and greater governmental support worldwide. With patients increasingly informed and advocacy efforts strong, companies are more inclined to meet these demands, recognizing the potential for both therapeutic impact and financial return in this niche market.
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐จ๐๐๐ฒ ๐๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ: https://www.maximizemarketresearch.com/inquiry-before-buying/342/
๐๐ซ๐ฉ๐ก๐๐ง ๐๐ซ๐ฎ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ:
There are significant opportunities for growth in the orphan drug market due to the increasing number of government incentives and patient advocacy initiatives aimed at addressing rare diseases. Pharmaceutical companies are encouraged to develop orphan drugs through benefits such as tax credits, grants, and extended market exclusivity, which have made orphan drug projects more financially viable. These incentives, along with the potential for premium pricing, create a favorable environment for expanding research and development in this field.
๐๐ก๐๐ญ ๐ข๐ฌ ๐๐ซ๐ฉ๐ก๐๐ง ๐๐ซ๐ฎ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ?
North America currently leads the orphan drug market, with the U.S. at the forefront due to strong regulatory incentives, including the FDA's exclusivity provisions and tax benefits for companies developing orphan drugs. These policies have driven high market participation, enabling more companies to address rare diseases and leading to a notable growth trajectory in the region. The United States' support for orphan drug research has resulted in a growing number of FDA-approved therapies, and this trend is anticipated to continue over the coming years.
๐๐ฎ๐ซ๐ข๐จ๐ฎ๐ฌ ๐๐๐จ๐ฎ๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ? ๐๐ซ๐๐ ๐๐จ๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐๐๐ฒ: https://www.maximizemarketresearch.com/request-sample/342/
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐๐ซ๐ฉ๐ก๐๐ง ๐๐ซ๐ฎ๐ ๐๐๐ซ๐ค๐๐ญ:
by Product
Biological
Non-Biological
by Disease Type
Oncology
Pancreatic Cancer
Ovarian cancer
Multiple Myeloma
Renal Cell Carcinoma
Others
Hematology
Hereditary Angioedema (HAE)
Hemophilia
Others
Neurology
Duchenne Muscular Dystrophy
Alzheimer's Disease
Huntington's Disease
Others
Cardiovascular
by Therapy Type
Oncology
Neuromuscular
Respiratory
Hematology
Others
by Distribution Channel
Hospital pharmacies
Retail pharmacies
Online pharmacies
others
๐๐ก๐จ ๐ข๐ฌ ๐ญ๐ก๐ ๐ฅ๐๐ซ๐ ๐๐ฌ๐ญ ๐ฆ๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐๐ซ๐ฌ ๐จ๐ ๐๐ซ๐ฉ๐ก๐๐ง ๐๐ซ๐ฎ๐ ๐๐๐ซ๐ค๐๐ญ ๐ฐ๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐?
1. Takeda Pharmaceutical Company Limited
2. Novartis AG
3. Johnson & Johnson
4. F. Hoffmann-La Roche Ltd
5. Bristol-Myers Squibb Company (Celgene Corporation)
6. Amgen Inc.
7. Bayer AG
8. Alexion Pharmaceutical Inc.
9. Novo Nordisk A/S
10. Pfizer Inc.
11. Eli Lilly and Company
12. Merck KGaA
13. Bristol-Myers Squibb Company
14. Amgen Inc.,
15. Alexion Pharmaceutical Inc
16. Bayer AG
17. Bristol Myers Squibb Co
18. Celegne Corporation
19. DAIICHI SANKYO Company Ltd
20. F. Hoffmann La-Roche
๐๐ง๐จ๐ฐ ๐๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.maximizemarketresearch.com/market-report/orphan-drugs-market/342/
๐๐๐ฒ ๐๐๐๐๐ซ๐ข๐ง๐ ๐ฌ:
Past Market Size and Competitive Landscape
LED Video Walls Market Size, Share, Size & Forecast by different segment
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
LED Video Walls Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐จ๐ซ๐: ๐๐ข๐ฌ๐ข๐ญ ๐๐ฎ๐ซ ๐๐๐๐ฌ๐ข๐ญ๐ ๐๐จ๐ซ ๐๐๐๐ข๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
โฆ Process Safety Services Market https://www.maximizemarketresearch.com/market-report/global-process-safety-services-market/41810/
โฆ Web Performance Market https://www.maximizemarketresearch.com/market-report/global-web-performance-market/1957/
โฆ AI Recruitment Market https://www.maximizemarketresearch.com/market-report/global-ai-recruitment-market/63261/
โฆ Global Animation Software Market https://www.maximizemarketresearch.com/market-report/global-animation-software-market/24079/
โฆ Payment Security Market https://www.maximizemarketresearch.com/market-report/global-payment-security-market/24755/
โฆ Data Integration Market https://www.maximizemarketresearch.com/market-report/global-data-integration-market/34124/
โฆ Fitness Equipment Market https://www.maximizemarketresearch.com/market-report/global-fitness-equipment-market/29892/
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ฑ๐ข๐ฆ๐ข๐ณ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
MAXIMIZE MARKET RESEARCH PVT. LTD.
โฎ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
โ +91 9607365656
๐ sales@maximizemarketresearch.com
๐ www.maximizemarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐๐ฑ๐ข๐ฆ๐ข๐ณ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orphan Drug Market Poised for Growth with 9.7% CAGR from 2024 to 2030 here
News-ID: 3735690 • Views: โฆ
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD
Ultrafiltered Milk Market Valued at USD 8.36 Billion in 2024, Anticipated to Gro โฆ
The Ultrafiltered Milk Market size was valued at USD 8.36 Billion in 2024 and the total Ultrafiltered Milk revenue is expected to grow at a CAGR of 4.6% from 2025 to 2032, reaching nearly USD 11.99 Billion.
Ultrafiltered Milk Market Overview:
Ultrafiltered milk is gaining increasing attention in the dairy and functional food sectors thanks to its enhanced nutritional profile. Through a specialized membrane filtration process, ultrafiltration concentrates higher-molecular weight componentsโฆ
Bath Towel Market to Grow from USD 10.46 Billion by 2032 at a CAGR of 6.7 %
The Bath Towel Market size reached USD 6.23 Bn in 2024 and is expected to reach USD 10.46 Bn by 2032, growing at a CAGR of 6.7 % during the forecast period.
Bath Towel Market Overview:
The bath towel industry is witnessing steady expansion, fueled by consumers' increasing focus on hygiene, comfort, and home aesthetics. High demand for plush, absorbent towels made of luxury materials such as Egyptian cotton, Turkish cotton,โฆ
Carob Market to Reach USD 374.76 Million by 2032 Growing at a 5.3% CAGR
The global Carob Market was valued at USD 247.92 million in 2024 and is projected to reach USD 374.76 million by 2032, expanding at a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2025 to 2032.
Carob Market Overview:
The carob market is experiencing significant growth, driven by its increasing popularity as a natural sweetener and plant-based alternative to chocolate. Derived from the seed pods of the carobโฆ
Welding Electrode Market Expected To Reach USD 11.27 Bn by 2032
The Welding Electrode Market size was valued at USD 5.70 Billion in 2024 and the total Welding Electrode revenue is expected to grow at a CAGR of 8.9 % from 2025 to 2032, reaching nearly USD 11.27 Billion.
Welding Electrode Market Overview:
The Welding Electrode Market is evolving as a critical segment within the global manufacturing and construction industries. Welding electrodes are essential consumables that enable reliable and efficient joining ofโฆ
More Releases for Orphan
Acquired Orphan Blood Disease Market
Acquired Orphan Blood Disease Market to reach over USD 18.93 billion by the year 2031 - Exclusive Report by InsightAce Analytic
According to a new report by InsightAce Analytic, the "Acquired Orphan Blood Disease Market" in terms of revenue was estimated to be worth $8.65 billion in 2023 and is poised to reach $18.93 billion by 2031, growing at a CAGR of 10.47% from 2024 to 2031.
Get Free Access toโฆ
Orphan Drugs Market Size to Hit $3199.3 Billion by 2028 | Orphan Drugs Industry โฆ
Market Overview:
According to our experience research team, Orphan Drugs Market was valued at USD 112.36 Billion in 2021, and the global Orphan Drugs industry is projected to reach a value of USD 3199.3 Billion by 2028, at a CAGR of 7.4% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy &โฆ
Orphan Drugs for Cancer Pipeline Analysis
A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developedโฆ
US Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.โฆ
Europe Orphan Drugs Pipeline Analysis
โEurope Orphan Drugs Pipeline Analysisโ by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drugโฆ
Global Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for theโฆ
